Search for Clinical Trial Results

Sponsored By

Hemorrhagic Fever - 27 Studies Found

Status Study
Recruiting Study Name: Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
Condition: Ebola Virus Survivor
Date: 2016-02-24
Interventions: Drug: Favipiravir Cohort 1: Day 1 (inclusion) 4800 mg (240
Completed Study Name: GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
Condition: Persistent Ebola Virus
Date: 2016-06-28
Interventions:
  • Drug: GS-5734 Daily GS-5734 de
Active, not recruiting Study Name: Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)
Condition: Prevention of Ebola Infection
Date: 2015-07-17
Interventions:
  • Biological: V920 Consistency Lot A

Not yet recruiting Study Name: MVA-BN®-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
Condition:
  • Ebola Disease
  • Marburg Disease

Date: 2016-09-01
Interventions:
  • Biological: Ad26 Zaire Ebola Vaccine

Completed Study Name: Evaluating an Ebola and a Marburg Vaccine in Uganda
Condition:
  • Ebola Virus Disease
  • Marburg Virus Disease

Date: 2009-10-16
Interventions:
  • Biological: Ebola vaccine 4 mg
Completed Study Name: Ebola and Marburg Virus Vaccines
Condition:
  • Ebola Vaccines
  • Marburg Virus Disease
  • Drug: VRC-EBODNA023-00-VP
  • Drug: VRC-MARDNA
Completed Study Name: Study on the Relationship Between Neutrophil-mediated Thrombocytopenia and the Condition and the Course of Disease in Patients With HFRS
Condition: Hemorrhagic Fever With Renal Syndrome
Date: 2025-08-02
Interventions: Based upon clinical classification of HFRS , the patients were classified into four types
<<< Previous